---
title: Sonogenetic control of EchoBack CAR-T cell activity within tumours 
categories:
- Article
excerpt: |
  Liu L, He P, Wang Y et al. screened the heat-shock promoters, which can be activated by focused ultrasound (FUS), to drive the expression of the chimeric antigen receptor (CAR) in T cells.
feature_text: |
  ## Control of the activity of CAR-T cells within tumours via focused ultrasound
---
Liu L, He P, Wang Y et al. screened the heat-shock promoters, which can be activated by focused ultrasound (FUS), to drive the expression of the chimeric antigen receptor (CAR) in T cells. A highly active FUS-responsive heatshock promoter was identified to control the CAR expression within tumours specifically. Such an approach reduces the off-tumour toxicity.
<img src="/assets/images/gr1_lrg.jpg">


<!-- more -->
Another spotlight for this study is the combination of different signalling cascades added to the CAR, reinforcing the activity of the T cells. For instance, the mini-promoters of human interleukin 2 (IL2), necrosis factor kappa B (NF-ÎºB), nuclear factor of activated T-cells (NFAT) and YB-TATA.
<img src="/assets/images/gr2_lrg.jpg">

<!-- more -->
<h3>Questions to be addressed</h3>
1. Why are CD8+ T cells, rather than CD4+ T cells, preferentially enriched in the EchoBack-CAR system compared with standard CAR T cells?
2. How is the safety profile of the EchoBack-CAR system in more biomimetic models?

<!-- more -->
<h3>Reference</h3>
<a href="https://www.cell.com/cell/abstract/S0092-8674(25)00271-5" target="_blank"> Liu, Longwei et al. Engineering sonogenetic EchoBack-CAR T cells. Cell, Volume 188, Issue 10, 2621-2636.e20 </a>
